
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Smoking Attributable Risk in Multiple Sclerosis
Ali Manouchehrinia, Jesse Huang, Jan Hillert, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 28
Ali Manouchehrinia, Jesse Huang, Jan Hillert, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target
Rongzeng Liu, Shushu Du, Lili Zhao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 81
Rongzeng Liu, Shushu Du, Lili Zhao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 81
Managing multiple sclerosis in individuals aged 55 and above: a comprehensive review
Óscar Fernández, Per Soelberg Sørensen, Gıancarlo Comı, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Óscar Fernández, Per Soelberg Sørensen, Gıancarlo Comı, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
A causal relationship between leukocyte telomere length and multiple sclerosis: A Mendelian randomization study
Qiao Liao, Jian He, Fafa Tian, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
Qiao Liao, Jian He, Fafa Tian, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
Plant-based production of an orally active cyclotide for the treatment of multiple sclerosis
Mark A. Jackson, Jing Xie, Linh T. T. Nguyen, et al.
Transgenic Research (2023) Vol. 32, Iss. 1-2, pp. 121-133
Open Access | Times Cited: 15
Mark A. Jackson, Jing Xie, Linh T. T. Nguyen, et al.
Transgenic Research (2023) Vol. 32, Iss. 1-2, pp. 121-133
Open Access | Times Cited: 15
Albumin and multiple sclerosis: a prospective study from UK Biobank
Ke Chen, Chunyu Li, Bi Zhao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Ke Chen, Chunyu Li, Bi Zhao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Early comorbidities and diagnostic challenges in people with multiple sclerosis with possible impact on disease management
Christine Makarov, Ewan Donnachie, Alexander Hapfelmeier, et al.
Multiple Sclerosis Journal - Experimental Translational and Clinical (2025) Vol. 11, Iss. 1
Open Access
Christine Makarov, Ewan Donnachie, Alexander Hapfelmeier, et al.
Multiple Sclerosis Journal - Experimental Translational and Clinical (2025) Vol. 11, Iss. 1
Open Access
The epidemiology, pathology and pathogenesis of MS: Therapeutic implications
Douglas S. Goodin
Neurotherapeutics (2025), pp. e00539-e00539
Open Access
Douglas S. Goodin
Neurotherapeutics (2025), pp. e00539-e00539
Open Access
Relation Between Smoking and Disability Progression in Iranian Multiple Sclerosis Patients: A Case-Control Study
Fereshteh Ashtari, Mahtab Sardashti Birjandi, Iman Adibi, et al.
International Journal of Preventive Medicine (2025) Vol. 16
Open Access
Fereshteh Ashtari, Mahtab Sardashti Birjandi, Iman Adibi, et al.
International Journal of Preventive Medicine (2025) Vol. 16
Open Access
Global burden of multiple sclerosis and its attributable risk factors, 1990–2019
Saeid Safiri, Amir Ghaffari Jolfayi, Seyed Ehsan Mousavi, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 3
Saeid Safiri, Amir Ghaffari Jolfayi, Seyed Ehsan Mousavi, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 3
Decoding multiple sclerosis: Unravelling the complexities of pathogenesis, progression, mechanisms and therapeutic innovations
Syeda Rida Zainab, Jehanzeb Khan, Muhammad Khalid Tipu, et al.
Neuroscience (2024)
Closed Access | Times Cited: 3
Syeda Rida Zainab, Jehanzeb Khan, Muhammad Khalid Tipu, et al.
Neuroscience (2024)
Closed Access | Times Cited: 3
Smoking affects epigenetic ageing of lung bronchoalveolar lavage cells in Multiple Sclerosis
Dennis Klose, Maria Needhamsen, Mikael V. Ringh, et al.
Multiple Sclerosis and Related Disorders (2023) Vol. 79, pp. 104991-104991
Open Access | Times Cited: 6
Dennis Klose, Maria Needhamsen, Mikael V. Ringh, et al.
Multiple Sclerosis and Related Disorders (2023) Vol. 79, pp. 104991-104991
Open Access | Times Cited: 6
Addressing Smoking in Persons With Multiple Sclerosis: State of the Science and Need for a Targeted Intervention
Carri S. Polick, Dana Rubenstein, Suma Shah, et al.
Nicotine & Tobacco Research (2023) Vol. 26, Iss. 2, pp. 250-252
Open Access | Times Cited: 5
Carri S. Polick, Dana Rubenstein, Suma Shah, et al.
Nicotine & Tobacco Research (2023) Vol. 26, Iss. 2, pp. 250-252
Open Access | Times Cited: 5
Resilience, mental health, sleep, and smoking mediate pathways between lifetime stressors and Multiple Sclerosis severity
Carri S. Polick, Hala Darwish, Leo Pestillo de Olivera, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Carri S. Polick, Hala Darwish, Leo Pestillo de Olivera, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Long-Term Disability Outcomes in Relapsing–Remitting Multiple Sclerosis Patients: Impact of Clinical and Demographic Factors on Disease Progression
Laura Bărcuțean, Smaranda Maier, Zoltán Bajkó, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 6, pp. 1813-1813
Open Access | Times Cited: 1
Laura Bărcuțean, Smaranda Maier, Zoltán Bajkó, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 6, pp. 1813-1813
Open Access | Times Cited: 1
The Role of Diet in Multiple Sclerosis Onset: A Prospective Study Using UK Biobank
Camilla Barbero Mazzucca, Lorenza Scotti, Cristoforo Comi, et al.
Nutrients (2024) Vol. 16, Iss. 11, pp. 1746-1746
Open Access | Times Cited: 1
Camilla Barbero Mazzucca, Lorenza Scotti, Cristoforo Comi, et al.
Nutrients (2024) Vol. 16, Iss. 11, pp. 1746-1746
Open Access | Times Cited: 1
Lifetime exposure to smoking and substance abuse may be associated with late-onset multiple sclerosis: a population-based case-control study
Naghmeh Abbasi Kasbi, Sajjad Ghane Ezabadi, Kosar Kohandel, et al.
BMC Neurology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Naghmeh Abbasi Kasbi, Sajjad Ghane Ezabadi, Kosar Kohandel, et al.
BMC Neurology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Fatigue and health-related quality of life depend on the disability status and clinical course in RRMS
Henrik Ahvenjärvi, Marja Niiranen, Sakari Simula, et al.
Multiple Sclerosis and Related Disorders (2023) Vol. 77, pp. 104861-104861
Open Access | Times Cited: 3
Henrik Ahvenjärvi, Marja Niiranen, Sakari Simula, et al.
Multiple Sclerosis and Related Disorders (2023) Vol. 77, pp. 104861-104861
Open Access | Times Cited: 3
Incidence and predictors of demyelinating disease in spondyloarthritis: data from a longitudinal cohort study
Patricia Remalante-Rayco, Adrian I. Espiritu, Yassir Daghistani, et al.
Lara D. Veeken (2023) Vol. 63, Iss. 7, pp. 1980-1986
Closed Access | Times Cited: 3
Patricia Remalante-Rayco, Adrian I. Espiritu, Yassir Daghistani, et al.
Lara D. Veeken (2023) Vol. 63, Iss. 7, pp. 1980-1986
Closed Access | Times Cited: 3
RISK FACTORS AND PREVENTION OF MULTIPLE SCLEROSIS
R.R. Aliyev, R.K. Shiraliyeva
NATIONAL JOURNAL OF NEUROLOGY (2023) Vol. 1, Iss. 23, pp. 18-27
Open Access | Times Cited: 1
R.R. Aliyev, R.K. Shiraliyeva
NATIONAL JOURNAL OF NEUROLOGY (2023) Vol. 1, Iss. 23, pp. 18-27
Open Access | Times Cited: 1
Smoking and Health-Related Quality of Life in Patients With Multiple Sclerosis From Latin America
Edgar Carnero Contentti, Juan Ignacio Rojas, Susana Giachello, et al.
International Journal of MS Care (2024) Vol. 26, Iss. Q3, pp. 187-193
Open Access
Edgar Carnero Contentti, Juan Ignacio Rojas, Susana Giachello, et al.
International Journal of MS Care (2024) Vol. 26, Iss. Q3, pp. 187-193
Open Access
Multiple Sclerosis: Immune Cells, Histopathology, and Therapeutics
Manisha S. Patil, Linda Yingqi Lin, Felix Marsh‐Wakefield, et al.
Sclerosis (2024) Vol. 2, Iss. 3, pp. 117-139
Open Access
Manisha S. Patil, Linda Yingqi Lin, Felix Marsh‐Wakefield, et al.
Sclerosis (2024) Vol. 2, Iss. 3, pp. 117-139
Open Access
Personality traits in patients with multiple sclerosis: their association with nicotine dependence and polypharmacy
Janina Meißner, Niklas Frahm, Michael Hecker, et al.
Therapeutic Advances in Neurological Disorders (2024) Vol. 17
Open Access
Janina Meißner, Niklas Frahm, Michael Hecker, et al.
Therapeutic Advances in Neurological Disorders (2024) Vol. 17
Open Access
Sclérose en plaques, les espoirs de la recherche
Armelle Rancillac, Céline Louapre, Brahim Nait‐Oumesmar, et al.
médecine/sciences (2024) Vol. 40, Iss. 10, pp. 770-773
Open Access
Armelle Rancillac, Céline Louapre, Brahim Nait‐Oumesmar, et al.
médecine/sciences (2024) Vol. 40, Iss. 10, pp. 770-773
Open Access
Resilience, Mental Health, Sleep, and Smoking Mediate Pathways Between Lifetime Stressors and Multiple Sclerosis Severity
Carri S. Polick, Hala Darwish, Leonardo Pestillo de Oliveira, et al.
Sclerosis (2024) Vol. 2, Iss. 4, pp. 341-354
Open Access
Carri S. Polick, Hala Darwish, Leonardo Pestillo de Oliveira, et al.
Sclerosis (2024) Vol. 2, Iss. 4, pp. 341-354
Open Access
Motivators and barriers for smoking cessation in people with multiple sclerosis: a qualitative study to inform the design of a tailored intervention
A. Keller, Barbara von Glasenapp, Daniel Kotz, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access
A. Keller, Barbara von Glasenapp, Daniel Kotz, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access